A study on the Russian Corona vaccine "Sputnik V" was published in the medical peer-review journal "Lancet."
The results of the third phase of the clinical trial of the vaccine indicate its efficacy rate is 91.6%. According to the study, the vaccine is equally effective among individuals aged 60 and above.